- Home
- NL vs INBX Comparison
NL vs INBX Comparison
Compare NL & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NL
- INBX
- Stock Information
- Founded
- NL 1891
- INBX 2010
- Country
- NL United States
- INBX United States
- Employees
- NL N/A
- INBX N/A
- Industry
- NL Major Chemicals
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- NL Industrials
- INBX Health Care
- Exchange
- NL Nasdaq
- INBX Nasdaq
- Market Cap
- NL 320.5M
- INBX 317.3M
- IPO Year
- NL N/A
- INBX 2020
- Fundamental
- Price
- NL $6.52
- INBX $24.26
- Analyst Decision
- NL Sell
- INBX Hold
- Analyst Count
- NL 1
- INBX 1
- Target Price
- NL $6.00
- INBX N/A
- AVG Volume (30 Days)
- NL 38.6K
- INBX 102.4K
- Earning Date
- NL 08-06-2025
- INBX 08-13-2025
- Dividend Yield
- NL 5.52%
- INBX N/A
- EPS Growth
- NL 141.37
- INBX N/A
- EPS
- NL 1.10
- INBX N/A
- Revenue
- NL $152,721,000.00
- INBX $1,400,000.00
- Revenue This Year
- NL $15.75
- INBX N/A
- Revenue Next Year
- NL $2.44
- INBX N/A
- P/E Ratio
- NL $5.98
- INBX N/A
- Revenue Growth
- NL N/A
- INBX N/A
- 52 Week Low
- NL $5.29
- INBX $10.81
- 52 Week High
- NL $9.42
- INBX $26.19
- Technical
- Relative Strength Index (RSI)
- NL 54.00
- INBX 66.16
- Support Level
- NL $5.70
- INBX $20.55
- Resistance Level
- NL $6.77
- INBX $22.10
- Average True Range (ATR)
- NL 0.36
- INBX 1.49
- MACD
- NL 0.07
- INBX -0.14
- Stochastic Oscillator
- NL 82.58
- INBX 74.05
About NL NL Industries Inc.
NL Industries Inc is a holding company that operates in the component products industry. Through its subsidiary, it manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. It also produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.